ABUS vs ADBE · P/E 5.4, rev $6.2M vs P/E 11, rev $13.02B
Arbutus Biopharma Corp (ABUS) versus Adobe Systems Incorporated (ADBE) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Adobe Systems Incorporated (ADBE) is a software - application company listed on NASDAQ. It is led by Shantanu Narayen.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ADBE revenue for 2026-05-29 was $13.02B. Net income was $3.60B. ADBE currently screens at market cap $78.02B and trailing P/E 11.2.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ADBE currently screens at market cap $78.02B and trailing P/E 11.2.
Not investment advice. Open the ABUS and ADBE stock pages for the full models.
Not investment advice.